Prostate Cancer Screening Deserves a Passing Grade
A federal task force that gave prostate cancer screening a D grade -- as in don't screen men who have no symptoms of the disease -- should bump that rating to a C, an MD Anderson scientist argues this week in a commentary in the Journal of the American Medical Association.
A grade C more closely fits available clinical evidence and will encourage clinicians to engage men in informed decision-making, a process that the D grade is...
Researchers Find Barriers to Multiple Myeloma Drugs and Keys to Unlock Them
MD Anderson researchers have identified molecular factors that erode the effectiveness of two important drugs for multiple...
Acute Myeloid Leukemia Patients Respond to New Combination
Adding a third drug to frontline combination therapy for acute myeloid leukemia resulted in an 85% complete remission...
Targeted Drugs Emerging for Chronic Lymphocytic Leukemia
A promising new class of drugs may shift treatment of the most common form of adult leukemia from combination chemotherapies to a more customized approach.
One such B cell receptor inhibitor, called PCI-32765, continues to show improved effectiveness in an ongoing clinical trial with relatively mild side effects compared to existing treatment.
Susan O'Brien, M.D., professor in MD Anderson's Department of Leukemia, will...
Exciting Advances in Inflammatory Breast Cancer at SABCS
Inflammatory breast cancer (IBC) is one of the most aggressive subtypes of breast cancer. The MD Anderson Morgan Welch Inflammatory...
Oncologist Joins Media at San Antonio Breast Cancer Symposium
Attending the San Antonio Breast Cancer Symposium for the past two years as a member of press is always a very pleasing and rewarding experience...
Combination Drug Therapy Promising for Advanced Breast Cancer
In an MD Anderson-led study presented at the San Antonio Breast Cancer Symposium today, researchers presented new data about a combination...
Targeted drug melts fat, weight and waistlines in obese monkeys
An experimental drug that directly reduces fat by destroying the blood vessels that support it caused an 11 percent weight loss in obese rhesus...
MD Anderson Researchers in the News: Prevention, Hodgkin Lymphoma
Powel Brown on 10 Years' Progress in Cancer Prevention
When online news service MedPage Today wanted some perspective on cancer prevention...
Texas Cancer Research Institute Funds 20 Projects at MD Anderson
The Cancer Prevention and Research Institute of Texas Wednesday awarded The University of Texas MD Anderson Cancer Center...
Advancing Cancer Prevention Through Technology
Some of the world's top minds in cancer research will gather this weekend to ponder new ways of ensuring that people won't ever need to seek...
Increased Prostate Cancer Risk for Men Who Take Vitamin E Supplements
New data released from the Selenium and Vitamin E Cancer Prevention Trial (SELECT) shows men who took daily doses of vitamin E had significantly...
BRCA2 Mutations in Ovarian Tumors Make Cancer Easier To Treat
Mutations of a tumor-suppressing gene that raise a woman's risk of developing ovarian cancer actually increase her chances of surviving the...
Idea Turns Into New Pancreatic Cancer Treatment
People across the world are mourning the death of Apple co-founder Steve Jobs, who passed away Wednesday, Oct 5, following a battle with pancreatic...
FDA Approves New Drugs for Lung Cancer, Melanoma, 2 Types of Lymphoma
Patients with four types of cancer have new treatment options available after approval of three new drugs by the United States Food and...
Targeted Gene Therapy Takes Down Breast Cancer Stem Cells
An intravenously delivered genetic bomb primed to go off only in breast cancer cells kills tenacious breast cancer-initiating cells, MD...
Proton Therapy Center National Education Conference: Day 2 Highlights
Day 2 of the Proton Therapy Center National Education Conference picks up where day 1 left off with insights into lung cancer, physics, dosimetry...
Proton Therapy Center National Education Conference: Day 1 Highlights
The Proton Therapy Center National Education Conference is designed to educate healthcare professionals on the recent advances, current treatment...
Chromatin Speaks! Cell Signal Receiver also Found To Transmit
A blend of histone proteins and DNA that packs genes into chromosomes, chromatin influences gene expression, DNA repair and chromosome recombination...
Hope For Couch Potatoes: Study Finds 15 Minutes of Daily Exercise Extends Life
It might not be quite as hard for physically inactive people to live longer by launching an exercise program as previously thought. In a study...
Scientists Detect Flawed Genetics of Head And Neck Cancers
Discovery of six mutated genes in head and neck squamous cell cancer provides an opportunity to develop customized treatment for the disease...
Key To Antibody Regulation Could Unlock New Treatments Via Immune System
Cancer evades or wards off attack by the immune system and even hijacks some aspects of the body's defenses against disease to thrive and...
GSBS Student Chases Details of Stray Neutrons in Proton Therapy
Publishing high-quality research is a major advantage for graduate students in today's climate of financial austerity and intense competition...
Personalized Therapy Benefits Late-Stage Cancer Patients in Clinical Trial
Customized treatment that matches specialized cancer drugs to their targets on each patient's tumor has been found to increase survival of...
Beta-Blockers Associated With Improved Relapse-Free Survival in Women With Triple-Negative Breast Cancer
A new study published May 31 in the Journal of Clinical Oncology reports that beta-blocker use is associated with improved relapse-free survival...
New Melanoma Drugs Raise Hopes, But More Choices Needed
After years of failure in the treatment of advanced melanoma, two new drugs have emerged that help patients with one of the most deadly and...
Gene Variation Links Lower Bladder Cancer Risk, Long Chromosome Tips
Like the plastic tips on shoelaces, telomeres sit at the end of chromosomes, protecting them from unraveling telomeres are protective, preventing...
Tyrosine-Kinase-Inhibitors May Be Effective in Common But Deadly Type of Lung Cancer
A type of drug that blocks the binding of cancer-promoting proteins may be suitable for treatment-resistant non-small cell lung cancer (NSCLC...
Discovery of Protein's Doubly Protective Role Wins Research Prize
MD Anderson researchers followed a surprising clue to discover that a known cancer-fighting protein also limits the growth of cells damaged...